LINSIGRA

WIPO WIPO 2021

Protect this trademark from copycats!

With our trademark monitoring alerts, you are automatically notified by email about copycats and free riders.

The International trademark LINSIGRA was filed as Word mark on 12/23/2021 at the World Intellectual Property Organization.

Trademark Details Last update: June 23, 2023

Trademark form Word mark
File reference 1644169
Countries Australia Canada Switzerland China European Community United Kingdom New Zealand
Base trademark US No. 90793302, June 24, 2021
Application date December 23, 2021
Expiration date December 23, 2031

Trademark owner

825 Industrial Road,
Suite 500
US

Trademark representatives

425 Market Street San Francisco CA 94105 US

goods and services

05 Pharmaceutical and therapeutic preparations for the treatment of gastrointestinal, skin, multi-organ, respiratory, ophthalmic, autoimmune, cardiovascular, central nervous system, endocrine, genetic, infectious, inflammatory, kidney, liver, menopausal, metabolic, musculoskeletal, neurodegenerative, neurological, neuromuscular, psychiatric, urogenital, urological, and/or viral diseases and disorders; pharmaceutical and therapeutic preparations for the treatment of eosinophilic gastritis, eosinophilic gastroenteritis, eosinophilic duodenitis, eosinophilic esophagitis, ulcerative colitis, crohn's disease, irritable bowel syndrome, functional gastrointestinal disease, chronic urticaria, atopic dermatitis, indolent systemic mastocytosis, mast cell activation syndrome, idiopathic pulmonary fibrosis, eosinophilic asthma, asthma, conjunctivitis, vitiligo, and viral infections

Trademark history

Date Document number Area Entry
December 28, 2022 2022/52 Gaz CH Rejection
October 4, 2022 2022/40 Gaz NZ Rejection
June 29, 2022 2022/26 Gaz EM Rejection
June 27, 2022 2022/26 Gaz CN Rejection
May 2, 2022 2022/23 Gaz GB Rejection
April 28, 2022 2022/22 Gaz AU Rejection
December 23, 2021 2022/4 Gaz US Registration

ID: 141644169